| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 1e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.28 | 3e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |